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Summary and Implications 
Lactating Holstein cows were assigned to 1 of 2 dietary 
iodine treatments at the Iowa State University Dairy farm.  
Objectives were to compare the bioavailability and 
production responses of an experimental product vs. an 
established iodine feed ingredient.  The two commercial 
iodine sources were both fed at increasing doses.  Results 
indicate a similar bioavailability between products and a 
linear increase in blood and milk iodine levels with 
increasing dose.  Dairy producers now have the necessary 
information to make educated decisions on choosing dietary 
iodine products.  
 
Materials and Methods 
Forty-eight lactating Holstein cows (3.25 ± 1.21 parity, 
133 ± 47 DIM, 670 ± 56 kg BW, 45.2 ± 8.4 kg milk yield) 
were assigned to 1 of 7 treatments at the Iowa State 
University Dairy farm.  Cows were milked twice daily 
(0700, 1900 h) and milk yields were recorded at each 
milking.  All cows were fed a total mixed ration (TMR) 
twice daily (0800 and 1600 h; there were no dietary changes 
throughout the trial) and orts/weigh-backs were not 
recorded.  The TMR was formulated by Dairy Health 
Services (Sanborn IA) to meet or exceed the predicted 
requirements of energy, protein, minerals and vitamins 
(Appendix 1).  All procedures were reviewed and approved 
by the Iowa State University Institutional Animal Care and 
Use Committee. 
 Cows were selected and moved to a common pen (48 
head capacity) 10 days prior to experiment initiation. Cows 
were assigned to 1 of 7 possible treatments based upon 
parity, days in milk (DIM) and milk yield.  
Iodine products were weighed (to 0.1 mg accuracy), 
inserted into size 11 (10 mL) porcine gelatin capsules 
(Torpac Inc.  Fairfield, NJ).  EDDI was 80% iodine, 
therefore 37.5, 75.0 and 112.5 mg of product was utilized 
for the 30, 60 and 90 mg supplements, respectively an 
referred to as “Product A”.  The Test Product (Zinpro’s 
iodine product) was 46% iodine, therefore 65.2, 130.4 and 
195.7 mg of product was utilized for the 30, 60, and 90 mg 
supplement, respectively and referred to as “Product B”.  
Farm staff and students were “blind” to treatment 
classification (i.e. which was A or B).  All capsules were 
orally administered (by bolus) daily to all cows for 14 
consecutive days.  Cows assigned to the control treatment 
received a capsule containing neither product.  Bolusing 
occurred while cows were “locked-up” immediately after 
cows returned to the pen after the AM milking. Cows were 
observed for 5 min following bolusing to ensure against 
regurgitation. 
 Milk samples from each cow (from both the AM and 
PM milking) were collected on d -2, -1, 3, 7, 10, 14, 17, 21, 
24 and 28 relative to treatment initiation. One sample from 
each collection was stored at 4°C with a preservative 
(bronopol tablet; D&F Control System, San Ramon, CA) 
until analysis by Dairy Lab Services (Dubuque IA) using 
AOAC approved infrared analysis equipment and 
procedures for milk components.  A weighted average 
(based upon the respective AM and PM milk yield) was 
calculated for each parameter.  An additional sample from 
each cow and each collection was shipped to Michigan State 
University’s Diagnostic Center for Population & Animal 
Health (Lansing, MI) for milk iodine analysis. 
Blood samples were obtained via coccygeal 
venipuncture on d – 3, -1, 3, 7, 10, 14, 17, 21, 24 and 28 
relative to treatment initiation using vacutainers designed 
for trace element testing (BD Vacutainer Ref 368380; 
Franklin Lakes, NJ).  Serum was harvested following 
centrifugation at 1500 x g for 15 min, and subsequently 
frozen at -20°C until analysis. Serum samples were sent (on 
dry ice) to Michigan State University’s Diagnostic Center 
for Population & Animal Health (Lansing, MI) for serum 
iodine analysis. 
Effects of treatment (1 to 7) and day (-4 or 28) and their 
interactions were assessed as a completely randomized 
design using PROC MIXED (SAS Inst. Inc., Cary, NC).  A 
repeated measures analysis with an autoregressive 
covariance structure and day as the repeated effect was used 
to determine effects of treatment day and their interaction on 
repeated measurements (i.e. milk and serum iodine levels, 
milk yield etc.). Data from this model are represented in the 
figures.  Production data and iodine levels (milk and serum) 
from d 7 to 14 (2
nd
 week of supplementation) were 
combined for each cow and statistically analyzed using the 
PROC MIXED procedure of SAS. All statistically analyzed 
data were covariately adjusted using their respective pre-
supplementation (d -4 to -1) values.  Results are reported as 
least squares means and considered different when P ≤ 0.05. 
 
Results and Discussion 
 Both serum and milk iodine values for the 2
nd
 week 
(average of d 7, 10 and 14) are presented in Table 1.  The 
smallest A dose (30 mg) did not increase (P > 0.05) blood 
iodine levels (compared to control) but B30 dose increased 
(P < 0.05) serum insulin 69% (compared to controls).  
Serum iodine levels did not differ amongst the lowest A or 
B dose (P > 0.05).  Compared to controls and A30, A60 
increased (P > 0.05) serum iodine by 106 and 50%, 
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respectively and there were no differences between A60 and 
B60 (Table 1).  Interesting, B30 was statistically similar (P 
> 0.05) to both A60 and B60. Both A90 and B 90 had a 
similar > 2 fold greater serum iodine concentration than 
controls and both had a 23% increased compared to A60 
and B60.  There were no differences (P > 0.05) between the 
time point when (d 10) each dose reach maximum serum 
levels (Table 2).  Maximum serum iodine levels mirrored 
that of the 2
nd
 week average (Table 2). 
 The serum AUC data was similar to the 2
nd
 week 
average, indicating that B30 (although not different [P > 
0.05] than A30) was similar to A60 and B60.  By d 14, both 
A90 and B90 serum iodine levels were larger (37%; P < 
0.05) than the A60 and B60 doses. In every measure, within 
every dose and within every day, product B always had a 
numerically higher serum iodine level compared to product 
A (Table 1 and 2). 
        In general, the differences between product, dose, day, 
and temporal pattern were similar in milk iodine 
concentrations compared to serum iodine levels (Table 1 
and 2.  Maximum milk iodine levels occurred on d 8 of 
supplementation but there were no differences amongst 
product or dose (P > 0.05; Table 2).  The increase above 
control levels during the 2
nd
 week of supplementation for 
the 30, 60 and 90 mg dose (independent of product) 
averaged 62, 157 and 293%, respectively (much higher than 
observed in the serum iodine concentrations; Table 1 and 2). 
  No treatment differences in any production parameter 
measured were detected (Table 1).  There was no treatment 
effect on milk SCC (Table 1) or SCS nor was there a 
relationship between milk iodine levels and SCS.  
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Table 1. Effects of increasing supplemental dietary iodine products (A and B) on production parameters and 
milk and serum iodine concentrations. 
 Treatment   
Variable Con A30 B30 A60 B60 A90 B90 SEM P 
Milk Yield, kg/d 43.17 45.46 44.49 44.32 43.86 43.53 45.02 0.84 0.53 
Fat, % 3.45 3.38 3.50 3.43 3.49 3.40 3.41 0.13 0.99 
Protein, % 2.91 2.93 2.93 2.95 2.90 2.90 2.89 0.03 0.74 
Lactose, % 4.80 4.76 4.79 4.78 4.79 4.77 4.79 0.03 0.98 
Total Solids, % 12.03 11.96 12.09 12.10 12.09 11.99 12.00 0.12 0.98 
MUN
a
, mg/dL 12.4 12.9 13.7 13.4 11.9 12.2 12.7 0.5 0.10 
SCC
b 
56 288 131 182 182 261 127 84 0.53 
Ln SCS
c 
1.69 1.87 1.92 1.95 1.84 2.00 1.78 0.11 0.50 
          
Milk Iodine, mu g/L 376
a 
561
ab 
664
b 
947
c 
983
c 
1113
cd 
1246
d 
74 <0.01 
Serum Iodine, ng/mL 78
a 
107
ab 
132
bc 
161
c 
161
c 
197
d 
200
d 
13 <0.01 
Data are from days 7 through 14 of supplemental period 
a
Milk urea nitrogen 
b
Milk somatic cell count 
c
Milk somatic cell score 
abcd
Indicates P < 0.05 
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Table 2. Effects of increasing supplemental dietary iodine products (A and B) on milk and serum iodine 
parameters. 
 Treatment   
Variable Con A30 B30 A60 B60 A90 B90 SEM P 
Milk AUC
a
, mu g x L x d          
   day 14 . 4422
a 
5301
a 
8286
b 
9788
b 
10279
bc 
11990
c 
732 <0.01 
Serum AUC, ng  x mL x d          
   day 14 . 707
a 
909
ab 
1200
bc 
1252
bc 
1610
d 
1745
d 
130 <0.01 
          
Day of maximum milk I . 8.2 8.7 10.7 7.7 10.7 9.9 1.3 0.44 
Day of maximum serum I . 8.3 9.5 12.9 10.6 10.2 9.0 1.2 0.16 
          
Maximum milk I, mu g/L . 689
a 
814
a 
1012
ab 
1238
b 
1225
b 
1381
b 
84 <0.01 
Maximum serum I, ng/mL . 118
a 
145
ab 
178
bc 
175
bc 
215
cd 
240
d 
17 <0.01 
a
Area under the curve 
abcd
Indicates P < 0.05 
 
